Search Results
Results found for "assay development"
- Dr. Katarina Nemec | Dr. GPCR Ecosystem
I am continuing with the development of advanced screening approaches in the Madan Babu lab to progress
- Chris Tate: Thermostabilizing GPCRs for Structural Biology | Dr. GPCR Ecosystem
His work developed the thermostabilization platform - a systematic approach to engineering receptor stability In 2005 he started working on the development of conformational thermostabilization of GPCRs, which resulted In 2016 mini-G proteins were developed as a tool for the structure determination of GPCRs in the fully
- Charlotte Crauwels: Designing Hybrid GPCRs with Computational Protein Engineering | Dr. GPCR Ecosystem
In this conversation, Charlotte Crauwels discusses her work developing computational strategies to support Her research centers on developing computational pipelines that guide the design of hybrid or chimeric Eventually, I connected with my current supervisor and began developing GPCR-related research projects Charlotte Crauwels: The goal of my PhD was to develop a computational pipeline that supports the design
- Dr. Kathleen Caron | Dr. GPCR Ecosystem
to elucidate the role of steroidogenesis in regulating sexual determination and adrenal and gonadal development
- Inês Pinheiro, Monserrat Avila Zozaya & Yamina Berchiche | Dr. GPCR Ecosystem
She developed expertise over the past two decades studying structure/function relationships of GPCRs
- Dr. Sudarshan Rajagopal | Dr. GPCR Ecosystem
Lefkowitz , where his research focused on biased agonism, with the development of approaches to quantify
- Dr GPCR Ecosystem Feedback | Dr. GPCR Ecosystem
Develop new tools, training programs, and mentorship programs tailored to your specific needs.
- Dr. Davide Calebiro | Dr. GPCR Ecosystem
To study GPCR signalling, they develop and use innovative optical methods based on FRET and single-molecule
- About Dr. GPCR Ecosystem | Uniting the GPCR Community to Advance Drug Discovery
Our goal is to deepen our understanding of GPCR function and accelerate the development of better therapies
- Dr. Bianca Plouffe | Dr. GPCR Ecosystem
In 2018, Bianca was appointed Vice-Chancellor’s Fellow at Queen’s University Belfast to develop her research
- Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
with receptors such as the μ-opioid and κ-opioid receptors, and how structural insights can guide the development interface of structural biology and drug discovery, where molecular structures inform the design and development One direction is to develop new tools using well-characterized receptors—the ones we understand well I can imagine myself in a biotech or pharmaceutical environment where I’m helping guide drug development Essentially serving as a bridge between the science and the development process. Dr.
- Dr. JoAnn Trejo | Dr. GPCR Ecosystem
the fundamental knowledge of GPCR biology and for the identification of drug targets and future drug development
- About Dr. GPCR Podcast | Dr. GPCR Ecosystem
I'm genuinely interested to see how it evolves and grows over time, as I feel it has the potential to develop
- Dr. Lauren M. Slosky | Dr. GPCR Ecosystem
understand how the principles of receptor allosterism and functional selectivity can be leveraged in the development
- The Scientist's Compass: From Academia to Entrepreneurship with Dr. Dmitry Veprintsev | Dr. GPCR Ecosystem
In 2021 he co-founded Z7 Biotech, developing and providing innovative GPCR drug screening and precision
- Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem
His work focuses on developing novel β₂-adrenergic ligands that selectively engage signaling pathways entrepreneur and founder of biotechnology companies translating GPCR pharmacology into therapeutic development Another company, Atrogi, is based on our research on β₂-adrenergic receptors and the development of new
- GPCR CRO Bank | Dr. GPCR Ecosystem
Build Trust Develop content that speaks their language and establishes your credibility in the GPCR research
- Donate to Dr GPCR — Support the GPCR Community & University
Help Us Close the Gap Between Academia and Biotech Together, we can accelerate GPCR discoveries and develop
- Dr. Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore | Dr. GPCR Ecosystem
During her time at Providence College, she received the Walsh Grant Fellowship to develop novel methods
- Brian Arey - Part 2: GPCR Drug Discovery and the Science Nobody Publishes | Dr. GPCR Ecosystem
contributions to multiple clinical programs including preclinical models that supported the apixaban development Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular
- EARNEST Panel: Can AI Accelerate GPCR Drug Discovery? | Dr. GPCR Ecosystem
Trained as a mathematician and computer scientist, his doctoral work focused on developing new methods machine learning since 1989, he built Pharos, the public-facing data platform for the IDG program, and co-developed
- University | Dr. GPCR Ecosystem
Aside from his vast experience in drug development, not to mention his extensive publication record, Summit A global gathering of researchers and professionals showcasing the latest developments in GPCR
- Elva Zhao: G Protein Regulation and Biased Signaling at the GLP-1 Receptor | Dr. GPCR Ecosystem
receptor, and whether that regulatory layer contributes to the therapeutic window problem that GLP-1 drug development Zhao describes how the objective of biased agonism research at the GLP-1 receptor is to develop ligand
- Media Partner Packages | Dr. GPCR Ecosystem
Build Trust Develop content that speaks their language and establishes your credibility in the GPCR research
- GPCR Masterclass Live Sessions | Dr. GPCR Ecosystem
Aside from his vast experience in drug development, not to mention his extensive publication record,
- GPCR Masterclass: Advanced Pharmacology & Drug Discovery | Dr. GPCR
Aside from his vast experience in drug development, not to mention his extensive publication record,
- Lauren Solano: Mapping Careers Beyond the Bench | Dr. GPCR Ecosystem
invisible to bench scientists, ranging from medical science liaison and clinical research roles to business development
- Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
A large component of his work is centered around dysregulated signaling in cancer and the development
- Univeristy Lecturers Details | Dr. GPCR Ecosystem
Aside from his vast experience in drug development, not to mention his extensive publication record,
- Affiliate Policy | Dr. GPCR Ecosystem
Responsibility for Your Site You are solely responsible for your website, including its development,




















